A citation-based method for searching scientific literature

Tamara L Lotan, Scott A Tomlins, Tarek A Bismar, Theodorus H Van der Kwast, David Grignon, Lars Egevad, Glen Kristiansen, Colin C Pritchard, Mark A Rubin, Lukas Bubendorf. Am J Surg Pathol 2020
Times Cited: 20







List of co-cited articles
165 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical implications of PTEN loss in prostate cancer.
Tamara Jamaspishvili, David M Berman, Ashley E Ross, Howard I Scher, Angelo M De Marzo, Jeremy A Squire, Tamara L Lotan. Nat Rev Urol 2018
242
50

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
40


A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
Thomas U Ahearn, Andreas Pettersson, Ericka M Ebot, Travis Gerke, Rebecca E Graff, Carlos L Morais, Jessica L Hicks, Kathryn M Wilson, Jennifer R Rider, Howard D Sesso,[...]. J Natl Cancer Inst 2015
122
35

PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.
Tamara L Lotan, Bora Gurel, Siobhan Sutcliffe, David Esopi, Wennuan Liu, Jianfeng Xu, Jessica L Hicks, Ben H Park, Elizabeth Humphreys, Alan W Partin,[...]. Clin Cancer Res 2011
242
35

Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Johann de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Oliver Sartor, Neeraj Agarwal, David Olmos,[...]. N Engl J Med 2020
601
30

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
30

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, Anthony V D'Amico, Brian J Davis, Tanya Dorff, James A Eastham, Charles A Enke, Thomas A Farrington, Celestia S Higano,[...]. J Natl Compr Canc Netw 2019
624
25

Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments.
Solène-Florence Kammerer-Jacquet, Amar Ahmad, Henrik Møller, Holly Sandu, Peter Scardino, Geraldine Soosay, Luis Beltran, Jack Cuzick, Daniel M Berney. Mod Pathol 2019
14
35

PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.
Tamara L Lotan, Wei Wei, Carlos L Morais, Sarah T Hawley, Ladan Fazli, Antonio Hurtado-Coll, Dean Troyer, Jesse K McKenney, Jeffrey Simko, Peter R Carroll,[...]. Eur Urol Focus 2016
50
25

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.
Emmanuel S Antonarakis, Farah Shaukat, Pedro Isaacsson Velho, Harsimar Kaur, Eugene Shenderov, Drew M Pardoll, Tamara L Lotan. Eur Urol 2019
93
25

Recurrent gene fusions in prostate cancer.
Chandan Kumar-Sinha, Scott A Tomlins, Arul M Chinnaiyan. Nat Rev Cancer 2008
513
25

Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
Scott E Eggener, R Bryan Rumble, Andrew J Armstrong, Todd M Morgan, Tony Crispino, Philip Cornford, Theodorus van der Kwast, David J Grignon, Alex J Rai, Neeraj Agarwal,[...]. J Clin Oncol 2020
70
20

Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
Rohit Mehra, Simpa S Salami, Robert Lonigro, Ritu Bhalla, Javed Siddiqui, Xuhong Cao, Daniel E Spratt, Ganesh S Palapattu, Nallasivam Palanisamy, John T Wei,[...]. Med Oncol 2018
11
36


Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.
M S Tretiakova, W Wei, H D Boyer, L F Newcomb, S Hawley, H Auman, F Vakar-Lopez, J K McKenney, L Fazli, J Simko,[...]. Prostate Cancer Prostatic Dis 2016
35
20

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.
Wassim Abida, Michael L Cheng, Joshua Armenia, Sumit Middha, Karen A Autio, Hebert Alberto Vargas, Dana Rathkopf, Michael J Morris, Daniel C Danila, Susan F Slovin,[...]. JAMA Oncol 2019
265
20

Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis.
Alejandro Berlin, Julio F Castro-Mesta, Laura Rodriguez-Romo, David Hernandez-Barajas, Juan F González-Guerrero, Iván A Rodríguez-Fernández, Galileo González-Conchas, Adrian Verdines-Perez, Francisco E Vera-Badillo. Urol Oncol 2017
36
20

Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.
Rahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, Li Zhang, Felix Y Feng, George V Thomas, Alana S Weinstein, Verena Friedl, Can Zhang, Owen N Witte,[...]. J Clin Oncol 2018
278
20

Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations.
Michael T Schweizer, Emmanuel S Antonarakis, Tarek A Bismar, Liana B Guedes, Heather H Cheng, Maria S Tretiakova, Funda Vakar-Lopez, Nola Klemfuss, Eric Q Konnick, Elahe A Mostaghel,[...]. JCO Precis Oncol 2019
42
20

PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.
Tamara L Lotan, Filipe Lf Carvalho, Sarah B Peskoe, Jessica L Hicks, Jennifer Good, Helen Fedor, Elizabeth Humphreys, Misop Han, Elizabeth A Platz, Jeremy A Squire,[...]. Mod Pathol 2015
102
20

Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
Michael S Leapman, Hao G Nguyen, Janet E Cowan, Lingru Xue, Bradley Stohr, Jeffry Simko, Matthew R Cooperberg, Peter R Carroll. Eur Urol 2018
21
20

A new era: artificial intelligence and machine learning in prostate cancer.
S Larry Goldenberg, Guy Nir, Septimiu E Salcudean. Nat Rev Urol 2019
107
15

The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.
Geert J L H van Leenders, Theodorus H van der Kwast, David J Grignon, Andrew J Evans, Glen Kristiansen, Charlotte F Kweldam, Geert Litjens, Jesse K McKenney, Jonathan Melamed, Nicholas Mottet,[...]. Am J Surg Pathol 2020
108
15


The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Jonathan I Epstein, William C Allsbrook, Mahul B Amin, Lars L Egevad. Am J Surg Pathol 2005
15

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Peter Ström, Kimmo Kartasalo, Henrik Olsson, Leslie Solorzano, Brett Delahunt, Daniel M Berney, David G Bostwick, Andrew J Evans, David J Grignon, Peter A Humphrey,[...]. Lancet Oncol 2020
138
15

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.
Phillip M Pierorazio, Patrick C Walsh, Alan W Partin, Jonathan I Epstein. BJU Int 2013
434
15

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
Eva Hollemans, Esther I Verhoef, Chris H Bangma, John Rietbergen, Jozien Helleman, Monique J Roobol, Geert J L H van Leenders. Mod Pathol 2019
42
15

Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.
Kenneth A Iczkowski, Kathleen C Torkko, Gregory R Kotnis, R Storey Wilson, Wei Huang, Thomas M Wheeler, Andrea M Abeyta, Francisco G La Rosa, Shelly Cook, Priya N Werahera,[...]. Am J Clin Pathol 2011
122
15

Classification of prostatic carcinomas.
D F Gleason. Cancer Chemother Rep 1966
751
15

Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.
Jesse K McKenney, Wei Wei, Sarah Hawley, Heidi Auman, Lisa F Newcomb, Hilary D Boyer, Ladan Fazli, Jeff Simko, Antonio Hurtado-Coll, Dean A Troyer,[...]. Am J Surg Pathol 2016
74
15


Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer.
Colin C Pritchard, Colm Morrissey, Akash Kumar, Xiaotun Zhang, Christina Smith, Ilsa Coleman, Stephen J Salipante, Jennifer Milbank, Ming Yu, William M Grady,[...]. Nat Commun 2014
175
15

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
Gail P Risbridger, Renea A Taylor, David Clouston, Ania Sliwinski, Heather Thorne, Sally Hunter, Jason Li, Gillian Mitchell, Declan Murphy, Mark Frydenberg,[...]. Eur Urol 2015
80
15

Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.
Jonathan I Epstein, Mahul B Amin, Himisha Beltran, Tamara L Lotan, Juan-Miguel Mosquera, Victor E Reuter, Brian D Robinson, Patricia Troncoso, Mark A Rubin. Am J Surg Pathol 2014
292
15

Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.
Tamara L Lotan, Wei Wei, Olga Ludkovski, Carlos L Morais, Liana B Guedes, Tamara Jamaspishvili, Karen Lopez, Sarah T Hawley, Ziding Feng, Ladan Fazli,[...]. Mod Pathol 2016
57
15

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
Himisha Beltran, Davide Prandi, Juan Miguel Mosquera, Matteo Benelli, Loredana Puca, Joanna Cyrta, Clarisse Marotz, Eugenia Giannopoulou, Balabhadrapatruni V S K Chakravarthi, Sooryanarayana Varambally,[...]. Nat Med 2016
784
15

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.
Mark M Pomerantz, Sandor Spisák, Li Jia, Angel M Cronin, Istvan Csabai, Elisa Ledet, A Oliver Sartor, Irene Rainville, Edward P O'Connor, Zachary T Herbert,[...]. Cancer 2017
152
15

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
819
15

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.
Johann S de Bono, Ugo De Giorgi, Daniel Nava Rodrigues, Christophe Massard, Sergio Bracarda, Albert Font, Jose Angel Arranz Arija, Kent C Shih, George Daniel Radavoi, Na Xu,[...]. Clin Cancer Res 2019
164
15

The mutational landscape of lethal castration-resistant prostate cancer.
Catherine S Grasso, Yi-Mi Wu, Dan R Robinson, Xuhong Cao, Saravana M Dhanasekaran, Amjad P Khan, Michael J Quist, Xiaojun Jing, Robert J Lonigro, J Chad Brenner,[...]. Nature 2012
15

MSH2 Loss in Primary Prostate Cancer.
Liana B Guedes, Emmanuel S Antonarakis, Michael T Schweizer, Nooshin Mirkheshti, Fawaz Almutairi, Jong Chul Park, Stephanie Glavaris, Jessica Hicks, Mario A Eisenberger, Angelo M De Marzo,[...]. Clin Cancer Res 2017
91
15

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ashley E Ross, Michael H Johnson, Kasra Yousefi, Elai Davicioni, George J Netto, Luigi Marchionni, Helen L Fedor, Stephanie Glavaris, Voleak Choeurng, Christine Buerki,[...]. Eur Urol 2016
165
15

Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.
Rohit Mehra, Aaron M Udager, Thomas U Ahearn, Xuhong Cao, Felix Y Feng, Massimo Loda, Joshua S Petimar, Philip Kantoff, Lorelei A Mucci, Arul M Chinnaiyan. Eur Urol 2016
91
15

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
John R Prensner, Matthew K Iyer, Anirban Sahu, Irfan A Asangani, Qi Cao, Lalit Patel, Ismael A Vergara, Elai Davicioni, Nicholas Erho, Mercedeh Ghadessi,[...]. Nat Genet 2013
482
15

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration.
Wassim Abida, Akash Patnaik, David Campbell, Jeremy Shapiro, Alan H Bryce, Ray McDermott, Brieuc Sautois, Nicholas J Vogelzang, Richard M Bambury, Eric Voog,[...]. J Clin Oncol 2020
190
15

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
David C Wedge, Gunes Gundem, Thomas Mitchell, Dan J Woodcock, Inigo Martincorena, Mohammed Ghori, Jorge Zamora, Adam Butler, Hayley Whitaker, Zsofia Kote-Jarai,[...]. Nat Genet 2018
120
10


Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges.
Joshua I Warrick, Margaret A Knowles, Allory Yves, Theo van der Kwast, David J Grignon, Glen Kristiansen, Lars Egevad, Arndt Hartmann, Liang Cheng. Am J Surg Pathol 2020
16
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.